Author

Eliot Morrison

Observed names: Morrison Eliot, Morrison, Eliot

Institution: Silence Therapeutics (Germany)

Observed institutions: Silence Therapeutics (Germany), San Francisco State University, Freie Universität Berlin

ORCID: 0000-0001-5456-3368

Observed ORCID: 0000-0001-5456-3368

OpenAlex ID: A5109163694

Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular disease

2022 · David A. Rider, Mona Eisermann, et al. · Atherosclerosis · 62

Structure and Mechanism of Styrene Monooxygenase Reductase: New Insight into the FAD-Transfer Reaction

2013 · Eliot Morrison, Auric Kantz, et al. · Biochemistry · 58

Quantification of HLA-DM-Dependent Major Histocompatibility Complex of Class II Immunopeptidomes by the Peptide Landscape Antigenic Epitope Alignment Utility

2018 · Miguel Álvaro-Benito, Eliot Morrison, et al. · Frontiers in Immunology · 44

PDF

Quantitative analysis of the human T cell palmitome

2015 · Eliot Morrison, Benno Kuropka, et al. · Scientific Reports · 43

PDF

Assessing Hybridization-Dependent Off-Target Risk for Therapeutic Oligonucleotides: Updated Industry Recommendations

2025 · Patrik Andersson, Sebastien A. Burel, et al. · Nucleic Acid Therapeutics · 38

PDF

Human leukocyte Antigen-DM polymorphisms in autoimmune diseases

2016 · Miguel Alvaro-Benito, Eliot Morrison, et al. · Open Biology · 37

Dynamic palmitoylation events following T-cell receptor signaling

2020 · Eliot Morrison, Tatjana Wegner, et al. · Communications Biology · 35

PDF

Distinct editing functions of natural HLA-DM allotypes impact antigen presentation and CD4+ T cell activation

2018 · Miguel Álvaro-Benito, Eliot Morrison, et al. · Cellular and Molecular Immunology · 30

Splicing-accessible coding 3′UTRs control protein stability and interaction networks

2020 · Marco Preussner, Qingsong Gao, et al. · Genome biology · 29

PDF

Preclinical Toxicological Assessment of A Novel siRNA, SLN360, Targeting Elevated Lipoprotein (a) in Cardiovascular Disease

2022 · David Rider, Simon Chivers, et al. · Toxicological Sciences · 14

PDF

CD4+ Th immunogenicity of the Ascaris spp. secreted products

2020 · Friederike Ebner, Eliot Morrison, et al. · npj Vaccines · 13

PDF

Human Hepatitis B Viral Infection Outcomes Are Linked to Naturally Occurring Variants of HLA-DOA That Have Altered Function

2020 · Austin M Graves, Francesca Virdis, et al. · The Journal of Immunology · 11

NS1 ‐mediated upregulation of ZDHHC22 acyltransferase in influenza a virus infected cells

2021 · Mohamed Rasheed Gadalla, Eliot Morrison, et al. · Cellular Microbiology · 9

PDF

The beauty of symmetry: siRNA phosphorodithioate modifications reduce stereocomplexity, ease analysis, and can improve in vivo potency

2024 · Sophie Schöllkopf, Stefan Rathjen, et al. · Molecular Therapy — Nucleic Acids · 8

The guanine-nucleotide exchange factor CalDAG GEFI fine-tunes functional properties of regulatory T cells

2017 · Jana Niemz, Stefanie Kliche, et al. · European Journal of Microbiology and Immunology · 5

PDF

Abstract 14720: Pre-clinical Safety Assessment of SLN360, a Novel Short Interfering Ribonucleic Acid Targeting LPA

2020 · David Rider, Daniel Swerdlow, et al. · Circulation · 2

CD4+ T Cell Epitope Identification from Complex Parasite Antigen Mixtures

2023 · Miguel Álvaro-Benito, Friederike Ebner, et al. · Methods in molecular biology · 1

Reversible Palmitoylierung von Proteinen

2017 · Eliot Morrison, Hannah Wiedemann, et al. · BIOspektrum · 1

Understanding the biological limits of hybridization-dependent siRNA off-target interactions

2026 · Luca Penso-Dolfin, Judith Hauptmann, et al. · Molecular Therapy — Nucleic Acids

Additional file 6 of Splicing-accessible coding 3′UTRs control protein stability and interaction networks